Revive Therapeutics Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (21)

View All

Latest Posts

About This Stock More About This Stock
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
Article By: Lorimer Wilson
Friday, April 1, 2022 8:25 AM EDT
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the Index.
In this article: ZYNE, CRBP, RVVTF, DMTTF, CYBN, NUMIF, MNMD, CMPS, FTRP, SEEL, ALID
Read
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
Article By: Lorimer Wilson
Monday, February 21, 2022 5:57 PM EDT
An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.
In this article: ATAI, MNMD, CMPS, ZYNE, RVVTF, TBPMF, ALID, CYBN
Read
Marijuana & Psychedelic Drug Stocks Continue To Decline
Article By: Lorimer Wilson
Sunday, January 16, 2022 3:00 AM EDT
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are psychedelic compounds-based drug stocks. 
In this article: ZYNE, CRBP, RVVTF, TBPMF, DMTTF, ALID, FTRP, NUMIF
Read
Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD
Article By: Lorimer Wilson
Friday, December 17, 2021 8:29 PM EDT
A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index.
In this article: MNMD, CMPS, ZYNE, CRBP, RVVTF, TBPMF, MYCOF, TRUFF, ALID, CYBN, FTRP, AWKNF
Read
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
Article By: Lorimer Wilson
Wednesday, December 1, 2021 4:25 PM EDT
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.
In this article: ATAI, CMPS, ZYNE, CRBP, RVVTF, MYCOF, TRUFF, ENVB, DMTTF, ALID
Read
All Posts

Latest Tweets for $RVVTF

No tweets yet!

PARTNER HEADLINES

$RVVTF

Comments Status Updates
Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
James Hunter • 3/25/2021 3:11:59 AM

Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."

1 to 1 of 1 comments